Welcome to our dedicated page for Haleon news (Ticker: HLN), a resource for investors and traders seeking the latest updates and insights on Haleon stock.
Haleon (HLN), a global leader in consumer health, provides science-backed solutions through trusted brands like Sensodyne and Advil. This page aggregates official announcements and financial updates essential for understanding the company’s strategic direction in oral care, pain relief, and wellness markets.
Access real-time press releases covering earnings reports, product innovations, regulatory milestones, and partnership developments. Investors gain critical insights into HLN’s operational performance while analysts track market positioning within the $1.5 trillion consumer health sector.
Key updates include R&D breakthroughs, sustainability initiatives, and geographic expansions. All content is sourced directly from Haleon’s communications to ensure accuracy and compliance with financial disclosure standards.
Bookmark this page for streamlined access to HLN’s evolving narrative. Combine our verified updates with Stock Titan’s analysis tools for informed decision-making in dynamic healthcare markets.
TUMS has partnered with DraftKings to launch TUMS Fantasy Foodball Pool, a free online game where players can draft food and drink combinations for a chance to win from a $40,000 prize pool. The initiative comes as a survey reveals that 25% of viewers prioritize food during the big game, with 54% believing gameday food can make or break the experience.
The game features four rounds from January 6 to February 9, each focusing on different themes: Tailgate Foods, Spicy Foods, Sweet Foods, and New Orleans Foods. Players can select from 36 items, including popular gameday foods like barbecue (34%), hot wings (33%), and seven-layer dip (24%). Former football champion Vince Wilfork has joined as a partner to promote the initiative.
TUMS will also host a public event at Bourbon Heat in New Orleans on February 7, offering product samples and exclusive merchandise. The survey, conducted by Talker Research, included 2,000 Americans aged 21-43.
Haleon has appointed Joe Sta-Romana as Chief Customer Officer (CCO) for its US business, effective December 1, 2024. Sta-Romana, who previously led Unilever's Walmart business and has over 20 years of experience in the FMCG sector, will lead the organization's customer strategy and drive growth in the US market. In his new role, he will focus on implementing customer-focused strategies, improving data analytics, enhancing digital solutions, and building stronger partnerships with key retailers. The appointment aims to strengthen Haleon's position in delivering better everyday health solutions through improved customer relationships.
Haleon has launched Eroxon®, the first FDA-cleared over-the-counter gel for erectile dysfunction (ED) in the U.S. Available for pre-order on Amazon and in major retailers by October 2024, Eroxon® is clinically proven to help men achieve erections within 10 minutes. This fast-acting treatment addresses a significant unmet need, as existing prescription solutions can take up to an hour to work.
Clinical studies demonstrate Eroxon®'s safety and efficacy for men with ED. The gel stimulates nerve endings in the penis to aid in achieving and maintaining erections. Haleon aims to make this accessible treatment available to millions of American men affected by ED, emphasizing the importance of sexual health in overall wellness.
Dr. Reddy's Laboratories announced the acquisition of Haleon's Nicotinell and related NRT brands for GBP 500 million. The acquisition includes Nicotinell's global portfolio, comprising Nicabate, Thrive, and Habitrol, across Europe, Asia, and Latin America. The deal features an upfront payment of GBP 458 million and performance-based payments of up to GBP 42 million. Nicotinell, the second-largest NRT brand globally, generated GBP 217 million in revenue in CY'23. Dr. Reddy's aims to expand its OTC business and strengthen its global consumer healthcare presence. The transaction is expected to close in early Q4 2024.
Yellow Wood Partners, a Boston-based private equity firm, announced that its portfolio company, Suave Brands Company, has completed the acquisition of the ChapStick brand from Haleon (LSE / NYSE: HLN). This acquisition also makes Haleon a shareholder in Suave Brands Company. The CEO of Suave Brands, Daniel Alter, stated that the addition of ChapStick fits their growth strategy and enhances their position in the North American beauty and personal care market. Suave Brands, known for offering affordable personal care products, now boasts annual retail sales of around $800 million. Yellow Wood Partners highlighted the strategic value of combining ChapStick with Suave, expanding product capabilities, and leveraging Suave's market presence. The acquisition aligns with Yellow Wood Partners' approach to value-creating acquisitions and organic growth strategies.
